Why Fenestra Research?

 

 

 

 

 

Your nutritional products will reach new heights with Clinical Trials conducted by Fenestra Research

There are Eight Proven Advantages for YOUR Company

 

1. Increased Credibility

2. More Sales

3. More Knowledge

4. More Effectiveness

5. Increased Confidence

6. Strong Foundation for new growth

7. Perfect timing - be safe/be compliant, lead the market

8. Highest ROI - By far the most cost effective study on the marketplace.

 

Fenestra's trials and subsequent reports throw open the window on the health benefits of using your product(s) and make clear not just what your product does but also exactly how it works. This gives you and your team new insight, understanding, and confidence to provide you with strong market share.

 

With Fenestra Research working with you, your market outreach is persuasive, conclusive, and inspiring. Furthermore, your claims may be backed by the hard science that today's marketplace demands. Whether you are looking to develop new markets, increase your current market share or move into new product directions, we can provide you with our research and development expertise for a fraction of the cost of conducting in-house trials with the enhanced credibility that comes from having third party study data.

 

Fenestra Research is unique in that Melonie Montgomery's proprietary process identifies and measures 34 cellular markers in human biochemistry to a very high degree of accuracy. Once a baseline is determined, the study will reveal positive (and/or negative) cellular changes when the product is introduced.  The resulting report gives the reader a powerful picture of exactly where and how much of the product being tested augments overall wellness.

 

It is important to understand that while the research is double blind and un-biased, Melonie and Fenestra Research are 100% on your team. Reports are written to highlight product benefits. Fenestra Research can also suggest formulation changes that will correct/improve benefits seen if necessary.

Fenestra Research Labs © 2005